Alain Chevallier
President bij Artedrone SAS
Profiel
Alain Chevallier is the founder of Splicos SAS, which was founded in 2008.
He currently holds director positions at OPALIA Pharma SA, Compagnie Immobilière et Commerciale SA, Charro Conseils SAS, and is the President of Artedrone SAS.
Mr. Chevallier's former positions include Chairman & Chief Executive Officer of Holding Incubatrice Chimie Verte SA, Chairman of Deinobiotics SAS from 2013 to 2016, Financial Director of Sanofi-Aventis France SA, Director of Carbios SA from 2016 to 2023, Chief Financial Officer & Finance Director of Abivax SA, Member-Executive Board of Aventis Pharma SARL, Principal of Bioring SA from 2009 to 2013, Chief Financial Officer of Deinove SA, and Partner of AEC Partners SAS.
He also served as Treasurer at the Institute of Cardiometabolisme Nutrition.
Mr. Chevallier earned an MBA degree from École des Hautes Études Commerciales de Paris.
Actieve functies van Alain Chevallier
Bedrijven | Functie | Begin |
---|---|---|
OPALIA Pharma SA
OPALIA Pharma SA Pharmaceuticals: MajorHealth Technology OPALIA Pharma manufactures generic drugs and pharmaceuticals. Its products specialize in the fields of dermatology, gastroenterology, rheumatology, and infectiology. The firm also provides consulting service. The company was founded by Marco Montanari and Alya El Hedda in 1988 and is headquartered in Ariana, Tunisia. | Director/Board Member | 23-10-2009 |
Compagnie Immobilière et Commerciale SA | Director/Board Member | - |
Artedrone SAS | President | - |
Charro Conseils SAS | Director/Board Member | - |
Eerdere bekende functies van Alain Chevallier
Bedrijven | Functie | Einde |
---|---|---|
CARBIOS | President | - |
ABIVAX | Director of Finance/CFO | 02-01-2017 |
Deinobiotics SAS
Deinobiotics SAS BiotechnologyHealth Technology Deinobiotics SAS researches and develops antibiotics and antifungals. The company was founded on June 19, 2012 and is headquartered in Grabels, France. | Chairman | 31-12-2016 |
Institute of Cardiometabolisme Nutrition | Treasurer | 01-12-2016 |
Holding Incubatrice Chimie Verte SA | Chief Executive Officer | 01-01-2016 |
Opleiding van Alain Chevallier
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CARBIOS | Commercial Services |
ABIVAX | Health Technology |
Bedrijven in privébezit | 13 |
---|---|
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the private company is based in Antony, France. | Health Technology |
Bioring SA
Bioring SA Medical SpecialtiesHealth Technology Bioring SA is a venture-backed company which designs, develops and markets new biodegradable medical devices and implants improving treatment outcome and reducing post treatment risk and complications. The Company's products originate from a proprietary know-how in chemical engineering and manufacturing which results in a unique technology platform combined with an expertise in medical device design and development. The Company's products find applications across the board, with a primary focus on cardiac surgery and urology. They can be implanted in standard open surgery as well as minimally invasive surgery, with or without a catheter. Bioring is funded by CDC Innovation, a leading French venture capital group, in addition to a number of business angels. The Company has taken its first product to the market in cardiac surgery in 2005 and has ongoing developments of other cardiac devices as well as promising urology products. Each one of these products addresses an opportunity of several hundred million dollars. Cardiac surgery The biodegradable Kalangos Rings for mitral and tricuspid valvuloplasty in adults and children is CE marked Cardiology Biodegradable stents for coronary arteries: in development Biodegradable membranes and support for percutaneous patent foramen ovale occlusion: in development Urology Biodegradable stents for male urethral implantation: in development Biodegradable prostheses for female urinary incontinence (FUI): in development | Health Technology |
Splicos SAS
Splicos SAS Miscellaneous Commercial ServicesCommercial Services Splicos SAS provides therapeutic research and development services. The firm specializes in generating therapeutic leads and drug candidates for cancer, HIV, and genetic diseases. It offers technologies in the fields of alternative splicing and metastatic migration. The company was founded in 2008 and is headquartered in Montpellier, France. | Commercial Services |
Deinove SA
Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
OPALIA Pharma SA
OPALIA Pharma SA Pharmaceuticals: MajorHealth Technology OPALIA Pharma manufactures generic drugs and pharmaceuticals. Its products specialize in the fields of dermatology, gastroenterology, rheumatology, and infectiology. The firm also provides consulting service. The company was founded by Marco Montanari and Alya El Hedda in 1988 and is headquartered in Ariana, Tunisia. | Health Technology |
AEC Partners SAS
AEC Partners SAS Investment ManagersFinance AEC Partners SAS provides corporate and financial advisory services. The company was founded by Garnier Christine and is headquartered in Paris, France. | Finance |
Holding Incubatrice Chimie Verte SA | Finance |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
Deinobiotics SAS
Deinobiotics SAS BiotechnologyHealth Technology Deinobiotics SAS researches and develops antibiotics and antifungals. The company was founded on June 19, 2012 and is headquartered in Grabels, France. | Health Technology |
Compagnie Immobilière et Commerciale SA | |
Institute of Cardiometabolisme Nutrition | |
Artedrone SAS | |
Charro Conseils SAS |